localized lichen myxedematosus with monoclonal gammopathy or systemic symptoms
MONDO:0019584
Localized lichen myxedematosus with monoclonal gammopathy or systemic symptoms is a form of atypical lichen myxedematosus, characterized by the appearance of several 2-4 mm erythematous waxy papules confined to a few sites that may be associated with either an immunoglobulin A (IgA) nephropathy in patients with acral persistent papular mucinosis; discrete papular lichen myxedematosus; a scleromyxedema-like involvement, with dysphagia, hoarseness, pulmonary involvement, and carpal tunnel syndrome; myositis without skin sclerosis; or paraproteinemia.
Outbreak surveillance
Global reported eventsExplore recent public health notices potentially related to localized lichen myxedematosus with monoclonal gammopathy or systemic symptoms. Results are keyword matches, not yet verified disease-to-outbreak relationships.
View localized lichen myxedematosus with monoclonal gammopathy or systemic symptoms on the outbreak map →localized lichen myxedematosus with monoclonal gammopathy or systemic symptoms
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.